Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Amortization of Deferred Charges (2021 - 2025)

Oncology Institute (TOI) has disclosed Amortization of Deferred Charges for 5 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortization of Deferred Charges fell 26.15% year-over-year to $1.2 million, compared with a TTM value of $8.8 million through Sep 2025, up 39.57%, and an annual FY2024 reading of $6.3 million, up 1.61% over the prior year.
  • Amortization of Deferred Charges was $1.2 million for Q3 2025 at Oncology Institute, up from $1.1 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $4.9 million in Q1 2025 and bottomed at $17000.0 in Q2 2021.
  • Average Amortization of Deferred Charges over 5 years is $1.4 million, with a median of $1.5 million recorded in 2022.
  • The sharpest move saw Amortization of Deferred Charges surged 4855.56% in 2022, then dropped 27.86% in 2025.
  • Year by year, Amortization of Deferred Charges stood at $18000.0 in 2021, then surged by 8522.22% to $1.6 million in 2022, then rose by 1.29% to $1.6 million in 2023, then increased by 1.4% to $1.6 million in 2024, then dropped by 26.47% to $1.2 million in 2025.
  • Business Quant data shows Amortization of Deferred Charges for TOI at $1.2 million in Q3 2025, $1.1 million in Q2 2025, and $4.9 million in Q1 2025.